Skip to content
Subscribe

California Democrats want one-year delay in registering controversial fumigant, methyl iodide

Published:

The joint Senate Assembly committee tasked with budgeting the current fiscal year is seeking to delay approval of a controversial fumigant for use on California strawberry fields.

Coastal agribusinesses are desperately searching for a new product to manage conventional farm pests since their old standby, methyl bromide, has been phased out by the federal government. Opponents argue (and a scientific review strongly demonstrated) that methyl iodide – the state's answer to its ozone-depleting counterpart – is highly toxic to humans.

Legislative Democrats are demanding that the Department of Pesticide Regulation (DPR) suspend registration for one year while a new independent study of methyl iodide goes forward. The DPR would also have to submit a report to the Legislature justifying any disagreements with the proposed review.  Although the department gave its preliminary approval of the fumigant in April, they are hearing public opinion before officially registering the product.

Ignoring the significant farm worker and public-health risks a scientific review panel associated with methyl iodide, the pesticide department has moved forward with registration. Pesticide regulation director, Mary-Ann Warmerdam attempted to justify the agency's actions in a hearing held on the issue last month by claiming application safeguards instituted by her department are stricter than federal mandates. Some members of the scientific panel expressed “horror” and “disgust” that the health protections do not and cannot go far enough.

Senator Dean Florez, D-Shafter, who led that hearing said, "If  is not willing to listen to its own scientific panel that it convened, then I think it is appropriate for the Legislature to step in and ask for a timeout on its use."

California classifies methyl iodide as a carcinogen. It has been shown to cause neurological damage, fetal death and thyroid cancer in laboratory animals. The long-term health impact on humans has not been studied enough, say scientists.

Senate and Assembly Republicans voted no on the proposal to forestall registration of methyl iodide saying this was not a matter for a budget committee to decide. The full legislature and the governor's office still have to approve the measure, but the likelihood of this is doubtful.

"The governor appreciates the Legislature's input on this important issue and urges them to work with the department on policy instead of trying to usurp the normal process," said executive spokewoman Rachel Arrezola.  Its an interesting state of affairs when the “normal process” lets executive fiat (instead of legislative mandate) arbitrate such a far-reaching matter.

Adhere to the IVN etiquette

By posting a comment, you agree to adhere to our etiquette rules: No partisan attacks, no personal attacks, substantiate your sources, no self-promotion.

Contact IVN

Questions about this article or our coverage? Send us a message. A free IVN member account is required.

Message sent

Thanks, we’ll review it and get back to you if needed.

Message not sent

Sorry, something went wrong. Please try again.

Sign in to send a message

Messages are tied to your IVN member account. Signing in is free and takes a few seconds.

Contact IVN

Questions about this article or our coverage? Send us a message. A free IVN member account is required.

Message sent

Thanks, we’ll review it and get back to you if needed.

Message not sent

Sorry, something went wrong. Please try again.

Sign in to send a message

Messages are tied to your IVN member account. Signing in is free and takes a few seconds.

Republish this article

Republishing guidelines

Republish IVN articles for free. Independent Voter News articles may be republished online or in print under a Creative Commons BY-NC-ND 4.0 license, on these terms:

  1. Credit the author and IVN. Keep the byline ("By Author Name, Independent Voter News") and the attribution note at the end, which links to the original.
  2. Keep the meaning. You may update time and place references and apply your house style. You may trim for length, as long as the cuts don't change the meaning or misrepresent the author. Keep the headline. Mark any additions as your own (for example "Additional reporting by ...").
  3. Translations are welcome. Translate faithfully, add "Translated from English by [your outlet]", and tell us at editor@ivn.us.
  4. Keep the links, including the link to the original article.
  5. Keep the tracking image. The HTML includes a 1-pixel image that counts readers on your page. It collects no personal information.
  6. Photos and illustrations. Images credited to IVN may be used with this article only. Images credited to others (AP, Getty, Unsplash, Wikimedia and so on) stay under their owners' terms. Secure the rights or switch "Include images" off.
  7. Don't sell it. You can't sell our articles or sell ads specifically against them. Your normal site advertising is fine.
  8. No implied endorsement. Don't suggest that IVN or the author endorses you, your candidates or your causes, or that donations to you support IVN.
  9. Keep labels. Opinion or analysis pieces keep that label.
  10. Point search engines to the original. Where your CMS allows, set the canonical URL to the original IVN article.
  11. No bulk or automated republishing, and don't submit our articles to aggregators (Apple News, Google News, MSN) as your own.
  12. Corrections and removals. Update your copy when we correct it, and remove it promptly if we ask. We'll contact you at the email you give us.
  13. Questions or print republication: editor@ivn.us.

IVN staff: fill in who you're inviting above, then create the invite.

Preparing the article

California Democrats want one-year delay in registering controversial fumigant, methyl iodide

Choose a format
  • HTML
  • Email HTML
  • Markdown
  • Formatted (.docx)
  • Plain text
  • WordPress blocks
  • PDF
Choose a platform

Photos credited to others need their owners' permission.

To for

Republishing somewhere else? Questions? editor@ivn.us